{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:13:44Z","timestamp":1790626424761,"version":"4.1.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Kyowa Kirin International"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Patients with X-linked hypophosphatemia (XLH) experience multiple musculoskeletal manifestations throughout adulthood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To describe the burden of musculoskeletal features and associated surgeries across the lifespan of adults with XLH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Three groups of adults were analyzed: subjects of a clinical trial, participants in an online survey, and a subgroup of the online survey participants considered comparable to the clinical trial subjects (according to Brief Pain Inventory worst pain scores of \u2265 4). In each group, the adults were categorized by age: 18-29, 30-39, 40-49, 50-59, and \u2265 60 years. Rates of 5 prespecified musculoskeletal features and associated surgeries were investigated across these age bands for the 3 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data from 336 adults were analyzed. In all 3 groups, 43% to 47% had a history of fracture, with the proportions increasing with age. The overall prevalence of osteoarthritis was &amp;gt; 50% in all 3 groups, with a rate of 23% to 37% in the 18- to 29-year-old group, and increasing with age. Similar patterns were observed for osteophytes and enthesopathy. Hip and knee arthroplasty was reported even in adults in their 30s. Spinal stenosis was present at a low prevalence, increasing with age. The proportion of adults with \u2265 2 musculoskeletal features was 59.1%, 55.0%, and 61.3% in the clinical trial group, survey group, and survey pain subgroup, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This analysis confirmed high rates of multiple musculoskeletal features beginning as early as age 20 years among adults with XLH and gradually accumulating with age.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab739","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T20:00:54Z","timestamp":1634500854000},"page":"e1249-e1262","source":"Crossref","is-referenced-by-count":47,"title":["Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-0048","authenticated-orcid":false,"given":"Muhammad Kassim","family":"Javaid","sequence":"first","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pinedo-Villanueva","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J","family":"Rylands","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Kyowa Kirin International, Marlow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Williams","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Kyowa Kirin International, Marlow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Insogna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-3467","authenticated-orcid":false,"given":"Erik A","family":"Imel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"1","key":"2022021713153750900_CIT0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1523-1755.2000.00807.x","article-title":"PHEX gene and hypophosphatemia","volume":"57","author":"Drezner","year":"2000","journal-title":"Kidney Int."},{"issue":"7","key":"2022021713153750900_CIT0002","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2022021713153750900_CIT0003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2022021713153750900_CIT0004","doi-asserted-by":"crossref","first-page":"153892","DOI":"10.1016\/j.metabol.2019.03.009","article-title":"Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)","volume":"103S","author":"Rothenbuhler","year":"2020","journal-title":"Metabolism."},{"issue":"1","key":"2022021713153750900_CIT0005","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect."},{"issue":"4","key":"2022021713153750900_CIT0006","doi-asserted-by":"crossref","first-page":"e1798-","DOI":"10.1210\/clinem\/dgaa064","article-title":"Osteoarthritis, osteophytes and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia","volume":"105","author":"Steele","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022021713153750900_CIT0007","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc."},{"issue":"5","key":"2022021713153750900_CIT0008","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis."},{"issue":"8","key":"2022021713153750900_CIT0009","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res."},{"key":"2022021713153750900_CIT0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2016.03.006","article-title":"Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status","volume":"87","author":"Curtis","year":"2016","journal-title":"Bone."},{"key":"2022021713153750900_CIT0011","volume-title":"Hip fracture: management. Clinical guideline 124","author":"National Institute for Health and Care Excellence","year":"2017"},{"issue":"2","key":"2022021713153750900_CIT0012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","article-title":"X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features","volume":"171","author":"Hardy","year":"1989","journal-title":"Radiology."},{"issue":"1","key":"2022021713153750900_CIT0013","first-page":"172","article-title":"Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project","volume":"34","author":"Jordan","year":"2007","journal-title":"J Rheumatol."},{"issue":"4","key":"2022021713153750900_CIT0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.080677","article-title":"Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project","volume":"36","author":"Jordan","year":"2009","journal-title":"J Rheumatol."},{"issue":"1","key":"2022021713153750900_CIT0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12891-016-1325-z","article-title":"Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview","volume":"17","author":"Gademan","year":"2016","journal-title":"BMC Musculoskelet Disord."},{"issue":"17","key":"2022021713153750900_CIT0016","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit Kremers","year":"2015","journal-title":"J Bone Joint Surg Am."},{"issue":"11","key":"2022021713153750900_CIT0017","doi-asserted-by":"crossref","first-page":"e031599","DOI":"10.1136\/bmjopen-2019-031599","article-title":"Assessment on patient outcomes of primary hip replacement: an interrupted time series analysis from \u2018The National Joint Registry of England and Wales\u2019","volume":"9","author":"Garriga","year":"2019","journal-title":"BMJ Open."},{"key":"2022021713153750900_CIT0018","article-title":"Change in the age distribution of patients undergoing primary hip and knee replacements over 13 years \u2013 an increase in the number of younger men having hip surgery","author":"Chidambaram","year":"2018","journal-title":"Orthopaedic Proceedings."},{"key":"2022021713153750900_CIT0019","article-title":"National Joint Registry. 17th Annual Report. National Joint Registry","author":"Registry NJ","journal-title":"National Joint Registry."},{"key":"2022021713153750900_CIT0020","volume-title":"Lower Limb Arthroplasty: Can We Produce a Tool to Predict Outcome and Failure, and is it Cost-Effective? An Epidemiological Study","author":"Arden","year":"2017"},{"issue":"2","key":"2022021713153750900_CIT0021","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s12325-019-01193-0","article-title":"Exploring the burden of X-linked hypophosphataemia: an opportunistic qualitative study of patient statements generated during a technology appraisal","volume":"37","author":"Ferizovi\u0107","year":"2020","journal-title":"Adv Ther."},{"issue":"13","key":"2022021713153750900_CIT0022","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jama.2010.338","article-title":"Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults","volume":"303","author":"Deyo","year":"2010","journal-title":"JAMA."},{"issue":"1","key":"2022021713153750900_CIT0023","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","article-title":"Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia","volume":"11","author":"Forestier-Zhang","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"12","key":"2022021713153750900_CIT0024","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2022021713153750900_CIT0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.joca.2010.10.025","article-title":"The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement","volume":"19","author":"Gossec","year":"2011","journal-title":"Osteoarthritis Cartilage."},{"issue":"9","key":"2022021713153750900_CIT0026","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.joca.2012.05.008","article-title":"Osteoarthritis patients\u2019 perceptions of \u201cappropriateness\u201d for total joint replacement surgery","volume":"20","author":"Frankel","year":"2012","journal-title":"Osteoarthritis Cartilage."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab739\/41072237\/dgab739.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/3\/e1249\/42544762\/dgab739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/3\/e1249\/42544762\/dgab739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T13:19:21Z","timestamp":1645103961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/3\/e1249\/6390759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,10,12]]},"published-print":{"date-parts":[[2022,2,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab739","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,10,12]]}}}